Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization

Abstract

Finally, the investigation demonstrated that intranasal delivery of mucoadhesive nanocarrier might play as a potential candidate in the management of Parkinson's disease and related brain disorders.